By Ben Glickman Shares of Verve Therapeutics rose Tuesday after fourth-quarter collaboration revenue came in ahead of expectations. The stock was up 16% to.
By Chris Wack Beam Therapeutics shares were up 31% to $47.02 after the company reported fourth-quarter earnings that beat analysts' expectations. The stock.
By Ben Glickman Shares of Tarsus Pharmaceuticals rose Tuesday after the company's product sales topped Wall Street's expectations. The stock was up 13% to.
By Chris Wack Capricor Therapeutics shares were up 8%, to $4.29, after the biotechnology company said it has been granted an in-person Type-B meeting with.